At a glance
- Originator Nippon Hypox
- Class Anti-inflammatories; Small molecules
- Mechanism of Action 5-lipoxygenase inhibitors; Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 25 Mar 1999 No-Development-Reported for Inflammation in Japan (Topical)
- 09 Sep 1996 Investigation in Inflammation in Japan (Topical)
- 29 Aug 1996 New profile